Immunogenicity of GLP-1 Peptide Analogues Immunogenicity refers to the ability of a drug to elicit an immune response, which may lead to the formation of anti-drug antibodies (ADAs)
generated lipid metabolite clusters corresponding to CT pathological findings (i.e., mass lesions, intraventricular hemorrhage, etc.), which revealed consistent downregulation of threonine, LPC (18:2 and 20:5), O-LPC (34:2, 34:3 and 36:3) and SM (40:1 and 40:2) in the presence of positive imaging findings
Unrestricted individual access to prweek.com Breaking news and industry updates via PRWeek Daily News bulletin Exclusive access to the Power Book and Top 150 UK consultancies report Start trial The Middle East Power Book is here Take a free trial out today to access: The Middle East Power Book - discover the most influential PR professionals in the region PRWeek Daily News and subscriber-only bulletins The PRWeek UK and EMEA podcast Start free trial Need to activate your subscription
doi: 10.1128/MCB.06465-11 29 PrieurXDolletLTakahashiMNemaniMPillotBLe MayCet al
~ AlphaMD Let's be honest
A dermatoscope with strong polarised light and 10 magnification is used to assess the symmetry of pigmented structures, e.g